Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07622927 · ClinicalTrials.gov registry record

FOCUS Bipolar: Families Opening Conversations for Understanding Signs

A clinical trial, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
200
Enrollment target

NCT07622927: Recruiting study, sponsored by University of Texas Southwestern Medical Center.

NCT07622927 is a clinical trial that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07622927 is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
200 participants
Enrollment target

Study Summary

Bipolar disorder often runs in families, but early symptoms in youth can go unrecognized for years. This project evaluates a structured, family-centered approach to informed screening for youth ages 7-21 who have a biological parent with bipolar disorder. The main questions addressed by this project are: Whether a co-designed video decision aid improves caregiver understanding of bipolar disorder genetic risk and supports informed decisions about youth screening. Whether remote mental health screening tools are feasible and acceptable for youth with familial risk for bipolar disorder. Whether screening results can be used to identify early risk patterns and inform tailored follow-up recommendations. Participants may be involved in one or more study activities, including co-design of educational decision-aid content, feedback on decision-aid prototypes, beta testing of the decision aid, and remote youth mental health screening. The study does not assign treatment and does not change existing clinical care or clinic routines.

Primary Outcome

Mean participant rating of decision aid acceptability using study-specific Likert-type items assessing clarity, balance, trustworthiness, and usefulness. Items are rated from 1 to 5, with 1 indicating strongly disagree and 5 indicating strongly agree. Higher scores indicate greater acceptability.

Interventions

  • OTHER Co-design Workshop (Observational Procedure)
  • OTHER Alpha Testing (Observational Procedure)
  • OTHER Beta Testing (Observational Procedure)
  • OTHER Youth Screening Pathway & Brief Follow-Up Interview (Observational Procedure)

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2026-03-11
Est. Completion 2027-07-31

What NCT07622927 shows while recruiting

NCT07622927 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 4 interventions - of which Co-design Workshop (Observational Procedure) is the first listed.

NCT07622927 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07622927 about?

NCT07622927 is a clinical study titled "FOCUS Bipolar: Families Opening Conversations for Understanding Signs". Bipolar disorder often runs in families, but early symptoms in youth can go unrecognized for years. This project evaluates a structured, family-centered approach to informed screening for youth ages 7-21 who have a biological parent with bipolar disorder. The main questions addressed by this projec...

What is the current status of trial NCT07622927?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2026-03-11. Estimated completion is 2027-07-31.

What interventions are being tested in trial NCT07622927?

The interventions under investigation include: Co-design Workshop (Observational Procedure) (OTHER), Alpha Testing (Observational Procedure) (OTHER), Beta Testing (Observational Procedure) (OTHER), Youth Screening Pathway & Brief Follow-Up Interview (Observational Procedure) (OTHER).

Who is sponsoring clinical trial NCT07622927?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07622927, the US trial registry maintained by the National Library of Medicine. NCT07622927 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.